Background : AT receptor activation has been demonstrated to cause increased vascular resistance properties which may be of 1 Ž . particular importance in the setting of congestive heart failure CHF . The overall goal of this study was to examine the effects of ACE Ž . inhibition ACEI alone, AT receptor blockade alone and combined ACEI and AT receptor blockade on LV pump function, systemic 1 1 hemodynamics and regional blood flow patterns in the normal state and with the development of pacing induced CHF, both at rest and Ž . Ž . with treadmill induced exercise. Methods and results: Pigs 25 kg were instrumented in order to measure cardiac output CO , systemic Ž . Ž . SVR and pulmonary vascular PVR resistance, neurohormonal system activity, and myocardial blood flow distribution in the conscious Ž . Ž . Ž . Ž . Ž . state and assigned to one of 4 groups: 1 rapid atrial pacing 240 bpm for 3 weeks n s 7 ; 2 ACEI benazeprilat, 3.75 mgrday and Ž . Ž . Ž . Ž . Ž . pacing n s 7 ; 3 AT receptor blockade valsartan, 60 mgrday and rapid pacing n s 7 ; and 4 ACEI and AT receptor blockade 1 1 Ž . Ž. benazeprilatrvalsartan, 1r60 mgrday, respectively and pacing n s 7 . Measurements were obtained at rest and with treadmill exercise Ž . 158, 3 milesrh; 10 min in the normal control state and after the completion of the treatment protocols. With rapid pacing, CO was reduced at rest and with exercise compared to controls. ACEI or AT blockade normalized CO at rest, but remained lower than control 1 values with exercise. Combination therapy normalized CO both at rest and with exercise. Resting SVR in the CHF group was higher than controls and SVR fell to a similar degree with exercise; all treatment groups reduced resting SVR. With exercise, SVR was reduced from rapid pacing values in the ACEI and combination therapy groups. PVR increased by over 4-fold in the rapid pacing group both at rest and with exercise, and was reduced in all treatment groups. In the combination therapy group, PVR was similar to control values with exercise. Plasma catecholamines and endothelin levels were increased by over 3-fold with chronic rapid pacing, and were reduced in all treatment groups. In the combination therapy group, the relative increase in catecholamines and endothelin with exercise were significantly blunted when compared to rapid pacing only values. LV myocardial blood flow at rest was reduced in the rapid pacing only and monotherapy groups, but was normalized with combination therapy. Conclusion: These findings suggest that with developing CHF, combined ACE inhibition and AT receptor blockade improved vascular resistive properties and regional blood flow distribution to a 1 greater degree than that of either treatment alone. Thus, combined ACEI and AT receptor blockade may provide unique benefits in the 1 setting of CHF. q 1998 Elsevier Science B.V. All rights reserved.
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Introduction
Functional characteristics of severe congestive heart Ž . Ž . failure CHF include left ventricular LV pump dysfunction, alterations in systemic hemodynamics, increased neu- rohormonal system activation, and exercise intolerance w x 1-7 . With the development of CHF, increased production Ž . of angiotensin II Ang-II occurs with resultant activation w x of the AT receptor system 2, 6, 8, 9 . Abundant AT recep- 1 1 tors have been located within a number of vascular beds including the pulmonary and coronary vasculature and
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( )activation of this receptor pathway causes vascular smooth w x muscle vasoconstriction 9-15 . Thus, heightened AT re-1 ceptor activation with CHF will cause increased vascular resistive properties which in turn may exacerbate the LV pump dysfunction and hemodynamic instability which occur with the development of this disease process. Past clinical studies have clearly demonstrated that angiotensin Ž . converting enzyme ACE inhibition improves LV funcw x tion and survival in the setting of CHF [16] [17] [18] . ACE inhibition has been demonstrated to produce multiple effects within the vascular system, which include prevention of Ang-II formation, potentiation of bradykinin levels, and w x modulation of nitric oxide production 14, [19] [20] [21] [22] [23] [24] . Past studies have demonstrated that combined ACE inhibition and AT receptor blockade may influence vascular resis-1 tive properties to a greater extent than either treatment w x alone 25,26 . Whether and to what degree specific interruption of AT receptor activity, as well as combined ACE 1 inhibition and AT receptor blockade influence systemic 1 hemodynamics and regional blood flow patterns in the setting of CHF remains unclear. Accordingly, the overall goal of this project was to determine the effects of ACE inhibition, AT receptor blockade, or combination therapy 1 on LV function, hemodynamics and regional blood flow patterns in the normal state and following the development of CHF; both at rest and with treadmill induced exercise.
Past reports from this laboratory and others have demonstrated that chronic pacing tachycardia in animals causes progressive and time dependent changes in LV geometry and pump function, and neurohormonal system w x activation 26-34 . While the stimulus which induces CHF in this model is dissimilar to clinical etiologies of CHF, the functional and neurohormonal changes which occur with chronic rapid pacing are similar to the clinical spectrum of w x this disease process 2-6,26,33,34 . In this model of CHF, the increased neurohormonal system activity is paralleled by increased systemic, pulmonary and coronary vascular w x resistance 11,26-28,30 . For example within the coronary vasculature, the development of pacing induced CHF is associated with diminished myocardial blood flow reserve w x 30 . Moreover, this model has been successfully used in order to determine the effects of exercise with the developw x ment of CHF 31 . Accordingly, in the present study, this model of pacing induced CHF was employed in order to examine the potentially differential effects of ACE inhibition, AT receptor blockade, and combined treatment on 1 systemic hemodynamics and regional blood flow patterns both at rest and with treadmill induced exercise.
Methods

Model of CHF and exercise
The present study employed a rapid pacing model of CHF in pigs which has been well described by this laboraw x tory previously 26,30,32 . Twenty-eight Yorkshire pigs Ž . 25 kg, male were chronically instrumented in order to measure hemodynamics and LV pump function in the conscious state. The pigs were anesthetized with isoflurane Ž . 3%r1.5 lrmin and a mixture of nitrous oxide and oxy-Ž . gen 50:50 , intubated with a cuffed endotracheal tube and ventilated at a flow rate of 22 mlrkgrmin and a respiratory rate of 15rmin. While maintaining a sterile field, the thoracic aorta was exposed through a left thoracotomy and Ž a catheter connected to a vascular access port Model . GPV, 9F, Access Technologies, Skokie, IL advanced into the aorta and sutured in place. Catheters were placed in the pulmonary artery and the left atrium in a similar fashion. The access ports were then placed in a subcutaneous Ž . pocket. A 20-mm flow probe Transonics, Ithaca, NY was placed around the pulmonary artery immediately distal to the pulmonary artery catheter and the electrical connection exteriorized through the thoracolumbar fascia. A shielded stimulating electrode was sutured onto the left atrium, Ž connected to a modified programmable pacemaker 8329, . Medtronic, Minneapolis, MN and buried in a subcutaneous pocket. The thoracotomy was closed in layers and the pleural space evacuated of air. All animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals Ž . National Research Council, Washington, 1996 .
Following a 14-21 day recovery from the surgical procedure, the animals were then returned to the laboratory for baseline studies as described in the following section. Following measurements under normal resting conditions and with exercise, the pigs were then randomly assigned to Ž . the following 4 Ž . mgrday, respectively and rapid pacing n s 7 . The drug treatment protocols were begun at the initiation of pacing and continued for the entire 21-day pacing protocol. To maintain a constant steady-state blood level of all com-Ž pounds used in this study, osmotic minipumps 2ML1, . w x Alza Corp were implanted in the peritoneal cavity 26 . This study employed a dosing strategy for ACE inhibition, AT receptor blockade, and combined ACE inhibition and 1 AT receptor blockade which has been demonstrated previ- 1 ously to obtain approximately a 50% inhibition of the Ang-I and Ang-II pressor response, but would not produce significant differential effects on resting blood pressure w x 26 . Cardiac auscultation and an electrocardiogram were performed frequently during the pacing protocol in order to ensure proper operation of the pacemaker and the presence of 1:1 conduction.
Measurements at rest and with exercise
On the day of the study, the animals were sedated with Ž diazepam 20 mg, p.o., Valium, Hoffmann-La Roche, Nutley, NJ and placed in a custom designed sling which allowed the animal to rest comfortably. This laboratory has demonstrated previously that sedation with benzodiapines produced no significant effect on resting hemodynamics w x 36 . All studies were performed in the conscious state without additional use of sedation. An ECG was estab-Ž . lished, and the pacemaker deactivated pacing groups only . After a 30-min stabilization period, LV function was measured by two-dimensional and M-mode echocardiographic Ž studies ATL Ultramark VI, 2.25-MHz transducer, Bothell,
. w x WA 30 . The vascular access ports were entered using a Ž . 12-gauge Huber needle Access Technologies, Skokie, IL , the flow probe was connected, and basal hemodynamics were recorded. The flow probe was connected to a digital Ž . flow-meter T106, Transonics, Ithica, NY as well as digitized to a computer for processing. From the digitized flow signal, stroke volume was computed on a beat-to-beat basis and averaged from a minimum of 25 ejections. Pulmonary and systemic vascular resistances were computed as the mean pressure divided by cardiac output multiplied by the constant 80 in order to convert to resistance units of dynes s cm y5 . From the arterial catheter, 30 ml of blood was drawn into chilled tubes containing Ž . Ž EDTA 1.5 mgrml , and centrifuged 2000 = g, 10 min, . 48C . The plasma was placed in separate tubes, frozen in liquid nitrogen, and stored at y808C for subsequent measurements of neurohormonal profiles, or valsartan levels. Samples were also drawn from the pulmonary artery and atrial catheters and immediately measured for oxygen satu-Ž ration and hemoglobin content CO-Oximeter, Instruments . Laboratory, Lawrence, MA . Oxygen content was calculated as the product of hemoglobin concentration and oxygen saturation which was then multiplied by the constant 1.34 in order to obtain oxygen values in ml O rdl. blood samples, fluorescent microspheres 3 = 10 , Molec-. ular Probes, Eugene, OR of specific emission spectra, w x were injected into the left atrium 37,38 . A reference aortic blood sample was withdrawn at a rate of 7 mlrmin which was initiated 5 s prior to injection and continued for 120 s following injection. The pigs were then exercised at a treadmill workload of 3 milesrh, at a 158 incline for a 10-min interval. In preliminary studies from this laboratory w x as well as consistent with past reports 39 , this treadmill protocol resulted in a near maximal heart rate for pigs. During the last minute of exercise, hemodynamics and blood samples were collected and microspheres delivered.
Neurohormonal profiles and drug leÕels
The plasma samples were assayed for renin activity, endothelin concentration, and catecholamine levels. Plasma renin activity was determined by computing angiotensin I Ž production using a radioimmunoassay procedure ARUP . Laboratories, Salt Lake City, UT . For the endothelin assays, the plasma was first eluted over a cation exchange Ž . column C-18 Sep-Pak, Waters Associates, Milford, MA and then dried by vacuum-centrifugation. The samples were reconstituted in 0.02 M borate buffer. A high sensitivity radioimmunoassay was performed to determine en-Ž dothelin concentrations Amersham, Arlington Heights, . IL . Plasma norepinephrine and epinephrine were measured using high performance liquid chromatography Ž . HPLC and normalized to pgrml of plasma. Plasma concentrations of valsartan were determined by an AT 1 receptor binding assay using smooth muscle cell memw x brane preparations as described previously 40 .
Regional blood flow measurements
All of the tissue samples were fixed in 10% formaldehyde in order to facilitate slicing. The mid-region of the LV free wall was separated into endocardial and epicardial layers weighing approximately 3 g each. Samples of approximately 3-5 g were also collected and prepared from the basal regions of the lung, kidney, diaphragmatic muscle, latissimus dorsi, and gluteus maximus. The tissue samples were carefully weighed and then digested using a potassium hydroxide solution as previously described w x 37,38 . The aortic blood samples were extracted using an identical digestion solution. The fluorescence of the extracted samples were then determined by spectrofluorime-Ž . try Gilford Fluoro IV, Oberlin, OH . The fluorescent microspheres used in this study with respect to excitationremission characteristics were: blue-green, 428r457 nm; orange, 534r550 nm; red, 580r594 nm; and scarlet, 650r674 nm, respectively. These fluorescent microspheres were chosen since a spectral scan which conformed to a Gaussian distribution could be uniformly obtained, minimal spectral cross-over occurred, and they w x provided equivalent sensitivity 38 . Regional blood flow computations were determined using the standard formula: . w x g 30 .
Data analysis
Indices of LV function and systemic hemodynamics were compared among the treatment groups using analysis of variance. If the analysis of variance revealed significant differences, pairwise tests of individual group means were compared using Bonferroni probabilities. For comparisons ( )of neurohormonal profiles, the Student-Neuman-Keul test was employed. All statistical procedures were performed Ž using the BMDP statistical software package BMDP Sta-. tistical Software, Los Angeles, CA . Results are presented as mean " s.e.m. Values of P -0.05 were considered to be statistically significant.
Results
LV function with pacing CHF: effects of ACE inhibition, AT blockade, and combination therapy 1
All of the pigs enrolled in the present study successfully completed the experimental protocols. In the concomitant AT receptor blockade and rapid pacing group, valsartan 1 plasma levels were 338 " 101 nmolrl and in the ACE inhibition and AT blockade group, plasma levels were 1 262 " 48 nmolrl, with no significant difference between Ž . groups P s 0.56 . These plasma levels for the AT antag-1 onist fell within the target therapeutic range determined w x from previously established dose response studies 26 .
Resting state
LV size and pump function for the treatment groups are presented in Fig. 1 and hemodynamic indices measured in the resting awake state for all of the treatment groups are summarized in Table 1 . Ambient resting heart rate was increased by 37% in the rapid pacing only group when compared to controls. In the combined treatment group, heart rate was lower than AT monotherapy values, but 1 remained increased from control values. Stroke volume was reduced by approximately 50% in the rapid pacing only group when compared to control values. In the ACE inhibition and combination therapy groups, stroke volume was higher than untreated pacing values and similar to control values. Systemic aortic pressure was lower in the rapid pacing only group and all three treatment groups when compared to controls. Pulmonary artery and left atrial pressures were increased by over 2-fold in the rapid pacing only group when compared to controls. While remaining increased from control values, pulmonary and left atrial pressures were reduced in the ACE inhibition and combination therapy groups when compared to rapid pacing only values. Systemic and pulmonary vascular resistances are presented in Fig. 2 .
Treadmill exercise
In all groups, respiratory rate significantly increased with treadmill exercise when compared to resting values Ž . Table 1 . In all rapid pacing groups, heart rate increased significantly from resting values with exercise, but remained lower than that achieved in the normal control state. In the rapid pacing only group, treadmill exercise resulted in a significant increase in stroke volume, but remained reduced from normal control values. Pulmonary artery and left atrial pressures remained increased in the Ž . Fig. 1 . Left ventricular LV end diastolic dimension and fractional shortening in conscious pigs under ambient resting conditions. With the development of Ž . Ž . pacing induced congestive heart failure CHF , end diastolic dimension increased, and fractional shortening decreased. With ACE inhibition ACEI , LV Ž . end diastolic dimension was decreased and fractional shortening was increased from rapid pacing only values. With AT receptor blockade AT -block , 1 1 Ž . end diastolic dimension and fractional shortening were similar to rapid pacing only values. With combination therapy ACEIrAT -block , end diastolic 1 dimension was decreased and fractional shortening was increased when compared to rapid pacing only. LV function was similar in the combination therapy Ž ) group when compared to the ACE inhibition group, and was significantly different from the AT receptor blockade group. P -0.05 vs. control;
. P -0.05 vs. rapid pacing only; P -0.05 vs. rapid pacing and ACEI; P -0.05 vs. rapid pacing and AT -block . Table 1 Systemic hemodynamics, LV function and geometry with pacing induced heart failure: effects of ACE inhibition, AT -Ang II receptor blockade, or combined ACE inhibition and AT -Ang II receptor 1 1 blockade during the progression of heart failure norepinephrine was higher when compared to the ACE inhibition or combination therapy groups. Plasma epinephrine was reduced in the combination therapy group when compared to rapid pacing only values, but this did Ž . not reach statistical significance P s 0.14 . In the rapid pacing only group, plasma endothelin increased by 3-fold from control values. Plasma endothelin was reduced in all treatment groups when compared to rapid pacing only values, but remained increased from control values. Plasma renin activity increased by 8-fold in the rapid pacing only group when compared to normal control values, and remained increased in all treatment groups.
The absolute change in plasma catecholamines in the normal control state and in all of the rapid pacing groups is summarized in Fig. 3 . The relative increase in plasma epinephrine was blunted only in the combination therapy group. In the combination therapy group, plasma endothelin levels fell from resting values with treadmill exercise. . P -0.05 vs. control; P -0.05 vs. rapid pacing only; P -0.05 vs. rapid pacing and ACEI; P -0.05 vs. rapid pacing and AT -block . 1 ever, in the combination therapy group, LV myocardial blood flow was normalized in both the endocardial and epicardial regions. Coronary vascular resistance is summarized in Fig. 4 . Pulmonary parenchymal flow was reduced by 50% from normal control values in the rapid pacing only group. Pulmonary blood flow was normalized in the ACE inhibition and combination therapy groups, but remained reduced in the AT receptor blockade group. Renal 1 blood flow was reduced in the rapid pacing only group and both monotherapy groups, when compared to normal control values. Renal blood flow was normalized in the combination therapy group. In the AT receptor blockade 1 group, skeletal muscle flow was reduced from control and rapid pacing only values.
Regional blood flow: effects of ACE inhibition
Treadmill exercise
LV myocardial blood flow increased by approximately 4-fold in the normal control state with treadmill exercise Ž . Table 2 . In the rapid pacing only group, LV myocardial blood flow increased with exercise, but was 38% lower than normal control values. LV myocardial blood flow remained reduced from control values in all treatment groups. Coronary vascular resistance with treadmill induced exercise is summarized in Fig. 4 . Pulmonary parenchymal flow increased by 4-fold in the normal control state with treadmill exercise, and was significantly blunted in the rapid pacing only group. In the ACE inhibition and combination therapy groups, pulmonary parenchymal flow increased from rapid pacing only values, but remained reduced from control values. Renal blood flow increased by 50% in the normal control state with exercise, but was reduced by 40% in the rapid pacing only group when compared to normal control values. Renal blood flow remained reduced in all treatment groups and was similar to rapid pacing only values. Skeletal muscle blood flow increased by over 5-fold in the control state Table 2 Blood flow with pacing induced heart failure: effects of ACE inhibition, AT -Ang II receptor blockade, or combined ACE inhibition and AT -Ang II receptor blockade during the progression of heart 1 . only; P -0.05 vs. rapid pacing and ACEI; P -0.05 vs. rapid pacing and AT -block . 1 and was significantly reduced in all of the rapid pacing groups. This was not affected by any drug treatment.
Discussion
The relative contribution of AT receptor activity to the 1 alterations in hemodynamic profiles which occur in the Ž . setting of severe congestive heart failure CHF is not fully understood. While AT receptor antagonists have been 1 w x successfully used in patients with CHF 41 , confounding influences such as multiple drug therapies, duration and degree of symptoms, duration of treatment, and methodological issues prevent the determination of the direct effects of AT receptor blockade on systemic hemody-1 namic profiles and regional blood flow patterns. Past studies have demonstrated that ACE inhibitors can influence a number of enzymatic pathways in addition to the reninw x angiotensin system 19-24,42 . Moreover, clinical and experimental studies have suggested that combined treatment with both ACE inhibition and AT receptor blockade may 1 provide additive effects with respect to vascular resistive w x properties 25 . Accordingly, the present study determined the effects of ACE inhibition, AT receptor blockade or
Systemic Õascular resistiÕe properties
In a past study, Symons and Stebbins reported that an acute infusion of losartan in normal pigs reduced systemic vascular resistance and increased myocardial blood flow w x with treadmill exercise 43 . In dogs with pacing induced CHF, Cheng and colleagues reported a significant increase in stroke volume following acute administration of losartan w x 44 . In a past report, this laboratory demonstrated that AT 1 receptor blockade reduced systemic and pulmonary vascuw x lar resistance in anesthetized pigs with CHF 26 . To our knowledge, the present study is the first to examine both hemodynamic and regional blood flow profiles at rest and with exercise following chronic ACE inhibition or AT 1 receptor blockade in a model of CHF. In the awake chronically instrumented state, chronic ACE inhibition or AT receptor blockade with developing pacing induced 
Myocardial blood flow and coronary Õascular resistance
w x Consistent with past reports 30,45 , the present study demonstrated that the development of pacing induced CHF was associated with a significant reduction in myocardial blood flow at rest. This reduction in myocardial blood flow occurred in the absence of a physical obstruction to flow and therefore was likely due to changes in vascular resistive properties of the coronary vasculature. It has been reported previously that in patients with non-ischemic cardiomyopathy, abnormalities in myocardial oxygen dew x liveryrdemand exist 46 . Thus, the global reduction in LV myocardial blood flow may be a contributory factor towards the diminished LV performance with pacing induced CHF. In the present study, chronic ACE inhibition improved resting LV epicardial blood flow and coronary vascular resistance, whereas chronic treatment with AT 1 receptor blockade failed to provide similar effects. Most importantly, the present study demonstrated that combined treatment normalized resting LV myocardial blood flow and reduced coronary vascular resistance to a greater degree than that of monotherapy with ACE inhibition. This reduction in coronary vascular resistance with combination therapy was achieved without a significant difference in resting blood pressure compared to the monotherapy groups. Thus, combined ACE inhibition and AT receptor 1 blockade in the setting of severe CHF may provide a beneficial means by which to improve resting myocardial blood flow without a compromise on systemic hemodynamics.
In a study by Sudhir and colleagues using an anesthetized dog model, the effects of the ACE inhibitor w x enalaprilat on coronary blood flow was examined 15 . In this past report, intracoronary administration of enalaprilat improved myocardial blood flow by approximately 19% when normalized to maximal flow achieved by adenosine. In patients with dilated cardiomyopathy, Foult and colleagues demonstrated that intracoronary administration of enalaprilat, which had no effects on systemic perfusion w x pressure, improved coronary sinus blood flow 13 . The present study builds upon these past reports by demonstrating that chronic combined ACE inhibition and AT recep-1 tor blockade improved resting myocardial blood flow to a greater degree than that of chronic ACE inhibition alone with the development of CHF. In order to more carefully examine LV myocardial blood flow under a physiological stress, measurements were also performed during treadmill induced exercise. Treadmill induced exercise increased relative LV myocardial blood flow in all treatment groups. However, with the development of pacing induced CHF, LV myocardial blood flow was reduced from control values with exercise. Unlike what was observed under resting conditions, LV myocardial blood flow was not significantly increased from pacing CHF values in any of the treatment groups with treadmill exercise. A number of vasoactive substances are locally released with increased myocardial work, which can significantly influence myw x ocardial blood flow characteristics 47 . With the development of pacing induced CHF, a blunted response to endothelial mediated vasodilation as well as to adenosine has w x been reported 30,48 . In addition, it has been suggested that the diminished coronary flow reserve with pacing induced CHF may be due to increased LV myocardial wall w x stress during diastole 45 . The findings of the present study would suggest that additional vasoconstrictive as well as mechanical influences, independent of either ACE or AT receptor mediated pathways, contribute to the 1 persistent reduction in LV myocardial blood flow during exercise in this model of CHF.
Regional blood flow distribution
With the development of CHF, pulmonary parenchymal flow was significantly reduced both at rest and with treadmill induced exercise. Parenchymal flow is supplied by the bronchial arteries with venous return through the pulmonary veins. Contributory mechanisms for the reduced bronchial flow with pacing CHF most probably include both hemodynamic and neurohormonal factors. For exam-Ž ple, increased hydraulic resistive pressure left atrial pres-. sure with pacing CHF likely contributed to the reduction in bronchial flow. In the ACE inhibition group, left atrial pressure was reduced from pacing CHF values and was accompanied by increased bronchial flow, both at rest and with exercise. Interestingly, AT receptor blockade did not 1 reduce left atrial pressure from pacing CHF values and in turn, was associated with no improvement in bronchial flow at rest or with exercise. Combination treatment, in which resting left atrial pressure was reduced from pacing CHF values, resulted in a normalization of resting bronchial flow. However, despite the significant reduction in left atrial pressure with treadmill exercise in both the ACE inhibition and combination treatment groups, bronchial flow remained lower than control values. In a report by w x Townsley et al. 49 , an enhanced vasoconstrictive response of the pulmonary vasculature to epinephrine was observed following the development of pacing induced CHF. Thus in the present study, inherent defects in the vasodilatory properties of the bronchial smooth muscle may have occurred with pacing CHF, which, in turn, contributed to the persistent defects in bronchial flow. While the contributory mechanisms for changes in bronchial flow with CHF are beyond the scope of the present study, these results do suggest that the defects in bronchial flow which occur with pacing induced CHF were probably not solely due to enhanced AT receptor 1 activity.
Resting skeletal muscle blood flow was lowest in the AT receptor blockade group when compared to either the 1 ( )ACE inhibition or combination therapy group. This observation was likely due to the fact that ACE inhibition and combination therapy attenuated circulating norepinephrine and endothelin to a greater degree than that of AT recep-1 tor blockade, and therefore improved relative muscle perfusion. With treadmill induced exercise, skeletal muscle blood flow was significantly reduced with pacing CHF. This is consistent with a past report in which abnormalities in skeletal muscle perfusion were noted in dogs with w x pacing CHF during treadmill exercise 28 . Chronic ACE inhibition, AT receptor blockade, or combination therapy 1 did not increase skeletal muscle blood flow from CHF values during exercise. With exercise, significant vascular smooth muscle vasodilation occurs primarily due to the w x local release of a number of metabolites 50 and the vascular response to these local metabolites has been w x reported to be abnormal with CHF 7 . These abnormalities in local vasodilatory response at the level of the muscle vasculature likely superseded any potential beneficial effects that inhibition of Ang-II formation or AT receptor 1 activation may have provided with treadmill induced exercise.
Neurohormonal actiÕity
w x Consistent with the clinical spectrum of CHF 2-6 , the development of pacing induced CHF was accompanied by increased sympathetic nervous system activity as evidenced by elevated plasma catecholamine levels. As reported previously by this laboratory, chronic ACE inhibition with the development of pacing CHF, reduced plasma norepinephrine levels under resting, ambient conditions w x 26,34 . In addition, and consistent with a recent report w x 26 , the present study demonstrated that concomitant AT 1 receptor blockade with developing pacing CHF did not cause a similar reduction in plasma norepinephrine. In the present study, combination ACE inhibition and AT recep-1 tor blockade, significantly reduced plasma norepinephrine from pacing CHF values. With treadmill exercise, plasma norepinephrine increased significantly in the pacing CHF group, and was reduced with either chronic ACE inhibition or combination treatment. Moreover, the relative increase in both norepinephrine and epinephrine with exercise was reduced to a greater degree in the combination therapy group. This overall reduction in sympathetic nervous activity with combined ACE inhibition and AT receptor block-1 ade, particularly with exercise may have contributed to the relative reduction in vascular resistive properties.
With the development of pacing CHF, increased plasma levels of the potent vasoactive peptide, endothelin have w x been reported 26,51 . One of the important findings of the present study was that combination treatment blunted the relative rise in plasma endothelin levels with treadmill exercise when compared to untreated CHF values or monotherapy treatment values. In patients with CHF, a relationship between circulating levels of endothelin and the degree of pulmonary vascular resistance has been w x reported 5,51 . For example, Tsutamoto and colleagues demonstrated that in patients with severe CHF, endothelin spillover in the pulmonary circuit occurred and correlated w x to the degree of pulmonary vascular resistance 51 . Kiowski et al. reported that acute administration of the non-selective endothelin receptor antagonist, bosentan, significantly reduced systemic and pulmonary vascular resisw x tance in patients with CHF 52 . In a model of CHF induced by chronic caval occlusion, Cannan and colleagues demonstrated that the coronary vasoconstrictor w x effects of endothelin were increased 53 . Thus in the present study, the relative reduction in plasma endothelin levels which occurred in the combination therapy group, particularly during treadmill induced exercise, likely contributed to the reduction in pulmonary and coronary vascular resistance.
With the development of pacing induced CHF, plasma renin activity was increased from control values both at rest and with exercise. With chronic ACE inhibition, AT 1 receptor blockade, or combination treatment, plasma renin activity remained increased from normal control values. This persistent elevation in plasma renin activity with ACE inhibition or AT receptor blockade was not surprising and 1 is consistent with interruption of the renin-angiotensin enzymatic pathway. The development of CHF has been demonstrated to cause changes in plasma and myocardial w x Ang-II levels 2,6,9,13,33,54-56 . Furthermore, alternative pathways for the local production of Ang-II have been w x identified 54,55 . Direct assessment of local production of Ang-II levels was not performed in the present study, and therefore the relative production of Ang-II and AT Ang-II 1 receptor activity could not be addressed. Future studies which directly examine Ang-II production within the LV as well as steady-state plasma levels following ACE inhibition, AT Ang-II receptor blockade, or combination ther-1 apy in this model of CHF are necessary in order to address this important study limitation.
LV function and geometry
Consistent with past reports from this laboratory and w x others 26-34,43,45 , chronic rapid pacing caused LV dilation and pump dysfunction. The progressive LV dilation which occurs with chronic rapid pacing results in recruitment of the Frank-Starling mechanism, but this mechanism is exhausted and results in diminished LV w x stroke volume with prolonged periods of pacing 29 . Concomitant ACE inhibition or combination treatment with chronic rapid pacing reduced the degree of LV dilation and improved LV pump function. The reduction in LV end-diastolic volume which was achieved through chronic ACE inhibition has been demonstrated previously to be paralleled at the cellular level by a reduction in isolated myw x ocyte resting length 26,34 . Because of the persistently elevated basal heart rate in the AT receptor blockade 1 ( )group, resting cardiac output was higher than pacing CHF values and similar to ACE inhibition and combination w x treatment. However, consistent with a recent report 26 , chronic AT receptor blockade with rapid pacing did not 1 provide similar effects with respect to LV dilation. In a recent study by Weinberg and colleagues, it was demonstrated that AT receptor blockade did not prevent LV 1 myocardial remodeling following chronic aortic stenosis in w x rats 57 , whereas these investigators demonstrated previously that ACE inhibition attenuated the LV myocardial w x remodeling in this model of hypertrophy 58 . The results from these reports as well as the present study suggest that the mechanisms of action of chronic ACE inhibition with respect to LV dilation and remodeling, are, at least in part, independent of Ang-II formation and subsequent AT re-1 ceptor activation.
Potential mechanisms for the effects of combination treatment
Chronic ACE inhibition reduced the degree of LV dilation, increased LV pump function and diminished neurohormonal system activity to a greater degree than that obtained with chronic AT receptor blockade with pacing 1 induced CHF. Combination therapy in which ACE inhibition was added to AT receptor blockade yielded beneficial 1 effects similar to that of ACE inhibition alone. The experimental design of the present study was predicated on past studies in which favorable effects on vascular resistance and blood flow have been reported with ACE inhibition w x 12,13,15 . However, it must be recognized that the effects of ACE inhibition on vascular tone may not be solely due to interruption of Ang-II formation. It is has been well established that ACE inhibitors can influence other enzyme systems and bioactive peptide levels such as w x bradykinin 14,20-24,42 . For example, in a recent study by Henrion and colleagues, the AT receptor antagonist 1 losartan only caused partial relaxation of rat resistance w x arteries when compared to ACE inhibition 10 . Furthermore, in this past study, arterial relaxation achieved through ACE inhibition was significantly attenuated in the presence of a bradykinin antagonist. Barra et al. recently demonstrated that AT receptor blockade did not induce 1 similar changes in compliance compared to ACE inhibition w x in a canine aortic preparation 14 . Hornig et al. reported that the vasodilatory effects of ACE inhibition in the radial artery of normal human subjects was primarily due to an w x accumulation of bradykinin 42 . In the present study, the differential effects between ACE inhibition and AT recep-1 tor blockade with respect to LV function and neurohormonal system activity was probably due to the differences in bradykinin levels. Furthermore, a potential mechanism for the additive effects of combined ACE inhibition and AT receptor blockade on vascular resistive properties is 1 probably due to a potentiated effect of ACE inhibition on alternative enzyme systems, such as the bradykinin pathway. In light of the findings of the present study as well as w x recent reports 24,42 , future studies which employ bradykinin receptor agonists and antagonists in this model of CHF are warranted.
In a recently completed study, receptor binding studies using LV myocardial preparations from normal and pacing CHF pigs revealed that the AT receptor was the predomi- density influence LV myocardial function and remodeling with developing CHF remain unclear. In a past report by this laboratory, chronic combined ACE inhibition and AT 1 receptor blockade returned myocardial Ang-II receptor w x density to near control levels 26 . Thus, a potential mechanism for the additive effects of combination therapy which were observed in the present study may have been due to favorable effects on AT receptor density and 
Study limitations and summary
The results of the present study hold clinical significance in light of the use of losartan, an AT receptor 1 antagonist, in the Evaluation of Losartan in the Elderly Ž . ELITE trial. In the ELITE study, AT receptor blockade 1 was well tolerated in patients with CHF, as evidenced by a low attrition rate. AT receptor antagonist treatment ap-1 peared to be associated with a reduction in all-cause w x mortality 61 . While additional studies using this model are warranted, combined ACE inhibition and AT receptor 1 blockade may be of particular benefit in the setting of CHF.
The present project employed a model of chronic rapid pacing which produced changes in LV functional and ( )neurohormonal characteristics similar to that of the clinical w x spectrum of CHF [1] [2] [3] [4] [5] [6] [7] 49 . Using this animal model of CHF provided an opportunity to determine the acute effects of AT receptor blockade in the absence of confound-1 ing influences which may be encountered in clinical studies. However, it must be recognized that any animal model will not fully represent the complex clinical spectrum of CHF. Specifically, the changes in LV myocardial structure which occur with pacing induced CHF are not similar to clinical forms of CHF due to chronic ischemia or hypertenw x sive disease 62 . Furthermore, this model of chronic rapid pacing for 3 weeks produces a rapidly progressive model of CHF which is in contrast to clinical forms of CHF which occur over a period of months to years. In a past clinical study, AT receptor blockade with losartan re-1 duced systemic vascular resistance in the setting of CHF; w x which appeared to be dose dependent 41 . Similar to this past clinical study, AT receptor blockade with the devel-1 opment of pacing induced CHF reduced systemic vascular resistance. However, in the present study, the dosage of AT receptor antagonist was selected based upon attenuat-1 ing the Ang-II pressor response and not producing a significant hypotensive effect when compared to that of w x ACE inhibition 26 . Thus, whether higher doses of either ACE inhibition, AT receptor blockade, or a combination 1 of both therapies may provide further beneficial effects on hemodynamics and neurohormonal profiles in the setting of CHF could not be addressed by the current experimental design. Furthermore, whether and to what degree ACE inhibition andror AT receptor blockade may influence 1 ventricular function, neurohormonal activity, and blood flow distribution in the normal myocardium was not addressed in the current experimental design. These limitations not withstanding, the present study demonstrated that in this model of CHF, the effects of ACE inhibition and AT receptor blockade did not provide equivalent effects 1 with respect to hemodynamics and neurohormonal profiles in the resting and exercise state. However, combination treatment improved vascular resistive properties, neurohormonal profiles and regional blood flow to a greater degree than with either treatment alone. The importance of these findings are two-fold. First, these results provide additional evidence that the mechanisms of action of ACE inhibition in the setting of CHF are not solely due to an attenuation of AT receptor activity. Second, combined ACE inhibi- 
